Ontario Teachers Pension Plan Board Decreases Holdings in Humana Inc. $HUM

Ontario Teachers Pension Plan Board reduced its holdings in shares of Humana Inc. (NYSE:HUM) by 61.9% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 254,162 shares of the insurance provider’s stock after selling 412,522 shares during the quarter. Humana makes up 1.2% of Ontario Teachers Pension Plan Board’s investment portfolio, making the stock its 19th biggest holding. Ontario Teachers Pension Plan Board owned about 0.21% of Humana worth $62,138,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in HUM. Cary Street Partners Investment Advisory LLC boosted its holdings in Humana by 63.9% in the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock valued at $31,000 after purchasing an additional 46 shares in the last quarter. Zions Bancorporation National Association UT purchased a new stake in shares of Humana during the 1st quarter worth approximately $37,000. CVA Family Office LLC boosted its holdings in shares of Humana by 63.4% in the 2nd quarter. CVA Family Office LLC now owns 219 shares of the insurance provider’s stock valued at $54,000 after buying an additional 85 shares in the last quarter. Ransom Advisory Ltd acquired a new position in shares of Humana in the 1st quarter valued at $66,000. Finally, Transamerica Financial Advisors LLC grew its position in shares of Humana by 1,027.6% in the 1st quarter. Transamerica Financial Advisors LLC now owns 327 shares of the insurance provider’s stock valued at $87,000 after buying an additional 298 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on HUM shares. Piper Sandler reduced their price target on shares of Humana from $288.00 to $272.00 and set a “neutral” rating for the company in a research report on Thursday, July 31st. Morgan Stanley cut their target price on Humana from $290.00 to $277.00 and set an “equal weight” rating on the stock in a research report on Thursday, July 31st. Mizuho upped their target price on Humana from $300.00 to $345.00 and gave the company an “outperform” rating in a research report on Thursday, October 9th. The Goldman Sachs Group started coverage on Humana in a research note on Tuesday, October 14th. They set a “sell” rating and a $235.00 price target on the stock. Finally, Sanford C. Bernstein boosted their price objective on Humana from $269.00 to $341.00 and gave the company an “outperform” rating in a research note on Friday, September 5th. Eight investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, Humana presently has a consensus rating of “Hold” and a consensus target price of $298.39.

Humana Stock Performance

Shares of HUM stock opened at $236.94 on Friday. The stock’s 50-day moving average price is $271.04 and its 200 day moving average price is $258.04. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69. The stock has a market capitalization of $28.50 billion, a PE ratio of 18.18, a price-to-earnings-growth ratio of 1.71 and a beta of 0.42. Humana Inc. has a 52-week low of $206.87 and a 52-week high of $315.35.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share for the quarter, beating the consensus estimate of $2.95 by $0.29. The company had revenue of $32.65 billion for the quarter, compared to the consensus estimate of $31.99 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The company’s revenue was up 11.1% on a year-over-year basis. During the same period last year, the business posted $4.16 EPS. As a group, equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.5%. The ex-dividend date is Friday, December 26th. Humana’s dividend payout ratio (DPR) is 33.18%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.